JIANXIN CAPITAL
Shanghai Jianxin equity is a Cci Capital Ltd focused on healthcare industry risk investment fund, has a professional investment team, the team has rich medical and financial investment, management and entrepreneurial experience, can make prospective investment layout according to the development trend of the industry, creating value for enterprises and investors. The company has a team of nearly 20 professional investment team, they were from medical institutions and financial class at home an... d abroad, with senior biomedical and financial professional background, have rich human resources in the field, the trend of development, familiar with domestic and international bio pharmaceutical industry research and development dynamics, can focus on the invested enterprise demand for product development, industrialization, management and financial investment and a full range of value-added services.
JIANXIN CAPITAL
Status:
Active
Contact:
021-62967868
Email Addresses:
[email protected]
Technology used in webpage:
SPF HiChina DNS China Telecom
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2020-10-26 | GeneCast Biotechnology | Jianxin Capital investment in Series E - GeneCast Biotechnology | N/A |
2020-03-25 | Abbisko Therapeutics | Jianxin Capital investment in Series C - Abbisko Therapeutics | 70 M USD |
2019-06-24 | Percutek Therapeutics | Jianxin Capital investment in Series D - Percutek Therapeutics | 100 M CNY |
2019-04-18 | Leads Biolabs | Jianxin Capital investment in Venture Round - Leads Biolabs | N/A |
2019-01-03 | Innocare | Jianxin Capital investment in Private Equity Round - Innocare | 160 M USD |
2018-08-29 | Leads Biolabs | Jianxin Capital investment in Series B - Leads Biolabs | N/A |
2018-07-27 | Sumgen Biotech | Jianxin Capital investment in Series A - Sumgen Biotech | 50 M CNY |
2018-02-06 | Eastern Biotech | Jianxin Capital investment in Angel Round - Eastern Biotech | 3 M CNY |
2017-11-08 | Huadao Biopharma | Jianxin Capital investment in Angel Round - Huadao Biopharma | 3 M CNY |
2017-07-03 | Leads Biolabs | Jianxin Capital investment in Series A - Leads Biolabs | N/A |